Yesterday Viral Genetics, Inc. (PINK:VRAL) rose 3.44% and reached a close of $0.0361 at a relatively huge volume of 6.5 million traded shares.
The price of VRAL stock has been on a relatively steady rise since the beginning of the month, basically riding on press releases and announcements. A somewhat curious fact is that the “news” from Nov. 30 and Dec. 9 actually inform that the company has initiated research coverage by Research 2.0, and that Haig Keledjian, CEO of Viral Genetics, will be featured…